Billets de Michelle Dawson

Billet publié sur Twitter/X le 29/05/2023 11:01

Twitter/X Publication avec DOI crossref Extrait cité dans le billet Question posée par Dawson dans le billet Lien intégré au billet Termes sur l’autisme

Liens cités structurés

1 ressource citée

Publication avec DOI Récupéré Publication crossref

Zoe Schmilovich, Vincent-Raphaël Bourque, Guillaume Huguet, Qin He, Jay P. Ross, Martineau Jean-Louis, Zohra Saci, Boris Chaumette, et al. (2023). Exploring the common genetic architecture of autism spectrum disorder using a novel multi-polygenic risk score approach. openRxiv.

Date de publication
28/05/2023
Identifiant
10.1101/2023.05.23.23290405
Auteurs
Zoe Schmilovich, Vincent-Raphaël Bourque, Guillaume Huguet, Qin He, Jay P. Ross, Martineau Jean-Louis, Zohra Saci, Boris Chaumette, Patrick A. Dion, Sébastien Jacquemont, Guy A. Rouleau
Type de référence
preprint
Éditeur
openRxiv
Source de métadonnées
crossref

Résumé

ABSTRACT Compared to disorders of similar heritability and contribution of common variants, few genome-wide significant loci have been implicated in autism spectrum disorder (ASD). This undermines the use of polygenic risk scores (PRSs) to investigate the common genetic architecture of ASD. Deconstructing PRS-ASD into its related traits via “developmental deconstruction” could reveal the underlying genetic liabilities of ASD. Using the data of >24k individuals with ASD and >28k of their unaffected family members from the SSC, SPARK, and MSSNG cohorts, we computed the PRSs for ASD and 11 genetically-related traits. We applied an unsupervised learning approach to the ASD-related PRSs to derive “multi-PRSs” that captured their variability in orthogonal dimensions. We found that multi-PRSs captured a similar proportion of genetic risk for ASD in cases versus intrafamilial controls (OR multi-PRS =1.10, R 2 =0.501%), compared to PRS-ASD itself (OR PRS-ASD =1.16, R 2 =0.619%). While multi-PRS dimensions conferred risk for ASD, they had “mirroring” effects on developmental phenotypes among cases with ASD. We posit that this phenomenon may partially account for the paucity of genome-wide significant loci and the clinical heterogeneity of ASD. This approach can serve as a proxy for PRS-ASD in cases where non-overlapping and well-powered GWAS summary statistics are difficult to obtain, or accounting for heterogeneity in a single dimension is preferable. This approach may also capture the overall liability for a condition (i.e.: genetic “P-factor”). Altogether, we present a novel approach to studying the role of inherited, additive, and non-specific genetic risk factors in ASD.

Auteur·ices de l’étude dans cette référence citée